Organon & Co. (OGN)
13.44
+0.02
(+0.19%)
USD |
NYSE |
May 20, 14:44
Organon EPS Diluted (Quarterly) : 0.5554 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.715 |
| Eli Lilly & Co. | 8.255 |
| Ligand Pharmaceuticals, Inc. | -0.6712 |
| Veradermics, Inc. | -0.8037 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 146.00M |
| Revenue (Quarterly) | 1.46B |
| Total Expenses (Quarterly) | 1.314B |
| Enterprise Value | 10.98B |
| Gross Profit Margin (Quarterly) | 54.11% |
| Profit Margin (Quarterly) | 10.00% |
| Earnings Yield | 6.98% |
| Operating Earnings Yield | 33.97% |
| Normalized Earnings Yield | 12.70 |